These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2892656)

  • 21. [Profile of pharmacological actions of NAB 365 (clenbuterol), a novel broncholytic agent with selective activity on adrenergic beta2-receptors (author's transl)].
    Engelhardt G
    Arzneimittelforschung; 1976; 26(7a):1404-20. PubMed ID: 12768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrophysiological and cyclic AMP responses to beta-adrenergic receptor stimulation and catecholamine levels in cat and rabbit sympathetic ganglion.
    Belan V; Macho L; Kvetnanský R; Machová J
    J Auton Nerv Syst; 1982 Mar; 5(2):119-33. PubMed ID: 6123531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of D-1 and D-2 dopamine antagonists on ERG and optic nerve response of the cat.
    Schneider T; Zrenner E
    Exp Eye Res; 1991 Apr; 52(4):425-30. PubMed ID: 2037020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of clenbuterol and prenalterol on performance during differential reinforcement of low response rate in the rat.
    O'Donnell JM
    J Pharmacol Exp Ther; 1987 Apr; 241(1):68-75. PubMed ID: 3572797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Beta adrenergic agonists. Mechanisms of action: lipid mobilization and anabolism].
    Lafontan M; Berlan M; Prud'Hon M
    Reprod Nutr Dev (1980); 1988; 28(1):61-84. PubMed ID: 2895488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulation of beta-adrenoceptors activates astrocytes and provides neuroprotection.
    Junker V; Becker A; Hühne R; Zembatov M; Ravati A; Culmsee C; Krieglstein J
    Eur J Pharmacol; 2002 Jun; 446(1-3):25-36. PubMed ID: 12098582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential anti-anaphylactic activity of clenbuterol, a beta-agonist with calcium antagonist properties.
    Frossard N; Frankhuyzen-Sierevogel JC; Binck M; Noordhoek J; Landry Y
    Agents Actions; 1985 Apr; 16(3-4):166-9. PubMed ID: 2409769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adrenergic effects on the corneal and intraretinal direct-current electroretinogram and on the standing potential of albino rabbit eyes.
    Jarkman S; Bragadóttir R
    Doc Ophthalmol; 1995; 89(3):251-66. PubMed ID: 7555593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of clenbuterol on the modulation of noradrenaline release in the rat tail artery.
    Encabo A; Ferrer M; Salaíces M; Manso R; Marín J; Balfagón G
    J Auton Pharmacol; 1996 Oct; 16(5):243-50. PubMed ID: 9023668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of clenbuterol on resting tension and contractile response in vesicourethral smooth muscle of rabbits.
    Kishimoto T; Aoki K; Okamiya Y; Takeshita T; Naruchi T
    Nihon Heikatsukin Gakkai Zasshi; 1989 Feb; 25(1):13-25. PubMed ID: 2576084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-adrenoceptor blocking effects of a selective beta 2-agonist, mabuterol, on the isolated, blood-perfused right atrium of the dog.
    Akahane K; Furukawa Y; Ogiwara Y; Haniuda M; Chiba S
    Br J Pharmacol; 1989 Jul; 97(3):709-16. PubMed ID: 2474351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenosine: autoradiographic localization and electrophysiologic effects in the cat retina.
    Blazynski C; Cohen AI; Früh B; Niemeyer G
    Invest Ophthalmol Vis Sci; 1989 Dec; 30(12):2533-6. PubMed ID: 2592165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. beta2-adrenergic receptor-selective agonist clenbuterol prevents Fas-induced liver apoptosis and death in mice.
    André C; Couton D; Gaston J; Erraji L; Renia L; Varlet P; Briand P; Guillet JG
    Am J Physiol; 1999 Mar; 276(3):G647-54. PubMed ID: 10070041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective regulation of beta-2 adrenergic receptors by the chronic administration of the lipophilic beta adrenergic receptor agonist clenbuterol: an autoradiographic study.
    Vos P; Davenport PA; Artymyshyn RP; Frazer A; Wolfe BB
    J Pharmacol Exp Ther; 1987 Aug; 242(2):707-12. PubMed ID: 2886650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced locomotor activity of rats mediated by peripheral beta adrenergic receptors.
    O'Donnell JM
    Res Commun Chem Pathol Pharmacol; 1993 Dec; 82(3):375-8. PubMed ID: 7907187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of various beta-adrenergic stimulant drugs on the serum cholinesterase levels of rats.
    Marmo E; Saini RK; Caputi AP
    Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):219-22. PubMed ID: 4405563
    [No Abstract]   [Full Text] [Related]  

  • 37. The influence of phosphodiesterase inhibitors on ERG and optic nerve response of the cat.
    Schneider T; Zrenner E
    Invest Ophthalmol Vis Sci; 1986 Sep; 27(9):1395-403. PubMed ID: 3744729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta2-adrenoceptor-mediated prejunctional facilitation and postjunctional inhibition of sympathetic neuroeffector transmission in the guinea pig vas deferens.
    Todorov LD; Clerkin R; Mihaylova-Todorova ST; Khoyi MA; Westfall DP
    J Pharmacol Exp Ther; 2001 Aug; 298(2):623-33. PubMed ID: 11454924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atypical pharmacologies at beta-adrenoceptors.
    Summers RJ
    Br J Pharmacol; 2008 Oct; 155(3):285-7. PubMed ID: 18641673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological modulation of nerve growth factor synthesis: a mechanistic comparison of vitamin D receptor and beta(2)-adrenoceptor agonists.
    Samina Riaz S; Tomlinson DR
    Brain Res Mol Brain Res; 2000 Dec; 85(1-2):179-88. PubMed ID: 11146120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.